Global EditionASIA 中文雙語Fran?ais
    Opinion
    Home / Opinion / Op-Ed Contributors

    China reaches a cloning milestone

    chinadaily.com.cn | Updated: 2018-01-26 07:50
    Share
    Share - WeChat
    Zhongzhong and Huahua, the world's first cloned monkeys using somatic cells, play in their chamber at the Chinese Academy of Sciences Institute of Neurosciences in Shanghai. Provided to China Daily

    On Thursday, the Institute of Neuroscience, Chinese Academy of Sciences, announced it had cloned two monkeys using non-reproductive somatic cell nuclear transfer in December. Three experts share their opinions on the issue with China Daily’s Zhang Zhouxiang:

    Welcome news, but we need a new law

    Since Dolly the sheep was cloned using somatic cell nuclear transfer in 1997, scientists around the world have been trying to clone primates. None of them succeeded until the Chinese team.

    More importantly, the Chinese team cloned a primate with non-reproductive cells, which is even more difficult than cloning animals through reproductive cell transfer. The biggest significance is that scientists can now use proper primates for medical tests. The research into many human diseases lags behind because scientists cannot conduct tests on humans. At present, researchers mainly conduct tests on animals such as mice, but there is a huge genetic difference between humans and mice.

    With the cloning of primates, it is possible to get large numbers of primates infected with the same diseases as humans, and conduct medical tests on them to find a cure. Such tests will be more effective because primates are genetically much closer to humans than mice.

    The cloning of monkeys has also aroused worries, especially raising the question: Will the technology be used to clone humans?

    The legislature needs to draft a new law and corresponding regulations on the issue to suit the needs of the times. Technology is neutral, but we need a specific law to prevent vested interests from abusing technology.

    Wang Yue, a professor at the Institute of Medical Humanities, Peking University

    Success will help find cure for diseases

    Currently, researchers can edit the genes of a single cell, but not the genes of an animal already born. With the technology used to clone the primates, we can get animals with edited genes.

    That’s very good news for neuroscience. Many genes, such as those causing Alzheimer’s disease, Parkinson’s disease and autism are similar in primates and humans. With the new technology, we can edit the genes of a monkey piece by piece to find out which gene caused a particular disease and how it can be re-edited leading to a cure.

    Besides, there are so-called “tool animals”, such as monkeys with optogenetics, which can be so gene-edited that their nerves are accurately controlled by light. Gene-editing is the only way of cloning these animals and the new technology makes that process much easier.

    Therefore, it would not be exaggerating to say the success of the Chinese team will make China a leader in the world of neuroscience.

    Tang Cheng, a research fellow in gene-editing studies at the Institute of Neroscience, Chinese Academy of Sciences

    Technology needs stronger rules

    Cloning animals is quite a mature technology, and there is little dispute over it. However, there are some questions that need answers. For example, will the cloning process cause irreparable damage to the animals? Will the cloned animals pose a threat to humankind?

    There are no detailed regulations on animal cloning yet, but some principles must be followed. According to the Human Genome Organization’s declaration on cloning technology in March 1999, the researchers who clone animals must take very good care of the animals, and the purpose of cloning must be made clear before beginning the process. And biodiversity must be given due consideration in the process.

    With the Chinese team’s success, cloning technology might achieve more progress in the future, which makes absolutely necessary to improve the regulations on cloning, so that it can better serve humankind.

    Zhang Tiankan, a former medical researcher and vice editor-in-chief to Encyclopedia magazine

    Most Viewed in 24 Hours
    Top
    BACK TO THE TOP
    English
    Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
    License for publishing multimedia online 0108263

    Registration Number: 130349
    FOLLOW US
    亚洲精品无码久久久久| 中文字幕免费视频一| 无码av中文一二三区| 少妇无码太爽了不卡视频在线看 | 少妇精品无码一区二区三区| 中文字幕日本在线观看| 无码专区一va亚洲v专区在线| 亚洲av日韩av无码黑人| 中文成人久久久久影院免费观看| 色吊丝中文字幕| 久久精品无码一区二区三区| 无码中文人妻视频2019| 狠狠精品久久久无码中文字幕| √天堂中文官网在线| 中文无码字慕在线观看| 亚洲AV无码专区日韩| 狠狠躁狠狠爱免费视频无码 | 亚洲中文字幕无码爆乳av中文| 亚洲中久无码不卡永久在线观看 | 成人午夜福利免费无码视频| 亚洲AV无码久久精品狠狠爱浪潮| 亚洲天堂2017无码中文| 人妻无码中文字幕免费视频蜜桃| 精品人妻中文字幕有码在线| 中文字幕精品无码一区二区三区 | 日本中文字幕在线2020| 日本中文字幕一区二区有码在线| 亚洲AV无码一区二三区| 亚洲一本大道无码av天堂 | 中文字幕一区二区精品区| 久久中文骚妇内射| 最近2019免费中文字幕视频三| 久久久久成人精品无码中文字幕| 亚洲中文字幕在线第六区| 熟妇人妻不卡中文字幕| 中文字幕视频一区| 亚洲伊人久久综合中文成人网| 中文精品久久久久人妻| 在线播放无码后入内射少妇| 无码人妻久久一区二区三区免费丨 | 亚洲AV无码国产精品麻豆天美|